I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a keen understanding of technological innovation in the industry. Today, we’re diving into the world of Tissue Regenix Group, a key player in regenerative
In the rapidly evolving field of synthetic biology, a groundbreaking study from the University of Warwick has unveiled a transformative approach to enhance the productivity of engineered microbial cell factories, as detailed in a recent publication in Nature Communications . These microscopic
In a groundbreaking move that has captured the attention of both the pharmaceutical industry and economic analysts, Eli Lilly and Co. has unveiled plans for a staggering $5 billion biomanufacturing facility in Goochland County, Virginia. Nestled in the West Creek Business Park, just a short
Cancer research has taken a remarkable leap forward with a recent study published in Nature Communications by Cao et al., shedding light on a previously unknown molecular mechanism that fuels tumor growth and opens new avenues for therapy. This groundbreaking work reveals a unique interaction
In the realm of virology, understanding how viruses interact with host cells is paramount to developing effective treatments and preventive measures, particularly for respiratory pathogens like the influenza A virus, which poses significant public health challenges. Traditional two-dimensional (2D)
The pharmaceutical industry stands at a critical juncture, where the urgent need for faster, more sustainable, and patient-focused solutions is driving unprecedented change, as vividly demonstrated at the DCAT Summit held on June 4–5 in Lugano, Switzerland. Under the compelling theme "Expedition
